187 related articles for article (PubMed ID: 37957550)
1. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B.
Yan P; Luo Y; Huang Z; Mou T; Yang H; Peng D; Wu Z
BMC Gastroenterol; 2023 Nov; 23(1):390. PubMed ID: 37957550
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes.
Tian J; Meng J; Yang Z; Song L; Jiang X; Zou J
Front Immunol; 2024; 15():1411161. PubMed ID: 38799437
[TBL] [Abstract][Full Text] [Related]
5. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
Wang W; Wang L; Song C; Mu T; Hu J; Feng H
J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
[TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
[TBL] [Abstract][Full Text] [Related]
9. A Six-Gene Prognostic Risk Prediction Model In Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Shen J; Shu M; Xie S; Yan J; Pan K; Chen S; Li X
Clin Invest Med; 2021 Oct; 44(3):E32-44. PubMed ID: 34600458
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J
Front Immunol; 2022; 13():994259. PubMed ID: 36341373
[TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
12. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
[TBL] [Abstract][Full Text] [Related]
14. A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma.
Yang J; Yang X; Guo J; Liu S
PeerJ; 2023; 11():e14622. PubMed ID: 36632140
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
16. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
17. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
[TBL] [Abstract][Full Text] [Related]
18. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
19. Identification of fatty acid metabolism-related clusters and immune infiltration features in hepatocellular carcinoma.
Ren Z; Gao D; Luo Y; Song Z; Wu G; Qi N; Li A; Liu X
Aging (Albany NY); 2023 Mar; 15(5):1496-1523. PubMed ID: 36881382
[TBL] [Abstract][Full Text] [Related]
20. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]